Risk & Volatility
IMAC has a beta of 1.68, indicating that its share price is 68% more volatile than the S&P 500. Comparatively, IMAC’s competitors have a beta of 0.94, indicating that their average share price is 6% less volatile than the S&P 500.
Profitability
This table compares IMAC and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IMAC | N/A | N/A | -325.44% |
| IMAC Competitors | -6.55% | -155.80% | -1.44% |
Valuation and Earnings
This table compares IMAC and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| IMAC | $72,050.00 | -$9.42 million | -0.00 |
| IMAC Competitors | $20.54 billion | $279.61 million | -241.30 |
Institutional & Insider Ownership
5.8% of IMAC shares are held by institutional investors. Comparatively, 58.0% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 12.3% of IMAC shares are held by insiders. Comparatively, 15.2% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
IMAC competitors beat IMAC on 5 of the 9 factors compared.
About IMAC
IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.
